Kazuhiko Hirano

Tokyo, Japan

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications

Case Report: transformation to SCLC from EGFR-mutated squamous cell lung carcinoma during osimertinib treatment.

Case Report: transformation to SCLC from EGFR-mutated squamous cell lung carcinoma during osimertinib treatment.

Journal: Frontiers in oncology
Published: March 03, 2026

Bruton tyrosine kinase inhibitor in non-IgM lymphoplasmacytic lymphoma: a case report and literature review.

Bruton tyrosine kinase inhibitor in non-IgM lymphoplasmacytic lymphoma: a case report and literature review.

Journal: Journal of clinical and experimental hematopathology : JCEH
Published: September 28, 2025

Durable responses and favorable cost-effectiveness of rituximab-based chemoimmunotherapy for primary cold agglutinin disease.

Durable responses and favorable cost-effectiveness of rituximab-based chemoimmunotherapy for primary cold agglutinin disease.

Journal: Blood research
Published: September 01, 2025

Pemigatinib therapy in myeloid/lymphoid neoplasm with FGFR1 rearrangement manifesting as aggressive B-cell lymphoma.

Pemigatinib therapy in myeloid/lymphoid neoplasm with FGFR1 rearrangement manifesting as aggressive B-cell lymphoma.

Journal: Journal of clinical and experimental hematopathology : JCEH
Published: June 29, 2025

Progression of IgM Monoclonal Gammopathy of Renal Significance (MGRS) to Symptomatic Waldenström Macroglobulinemia: A Case Report.

Progression of IgM Monoclonal Gammopathy of Renal Significance (MGRS) to Symptomatic Waldenström Macroglobulinemia: A Case Report.

Journal: Cancer reports (Hoboken, N.J.)
Published: February 26, 2025

Impact of chromosomal aberrations detected by chromosome banding analysis in symptomatic Waldenström's macroglobulinemia.

Impact of chromosomal aberrations detected by chromosome banding analysis in symptomatic Waldenström's macroglobulinemia.

Journal: Annals of hematology
Published: July 14, 2024

Efficacy and safety of therapeutic procedure for Waldenström's macroglobulinemia with hyperviscosity syndrome.

Efficacy and safety of therapeutic procedure for Waldenström's macroglobulinemia with hyperviscosity syndrome.

Journal: Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy
Published: September 07, 2023

Extramedullary hematopoietic pleural effusion in Waldenström's macroglobulinemia.

Extramedullary hematopoietic pleural effusion in Waldenström's macroglobulinemia.

Journal: EJHaem
Published: April 24, 2023

A Rare Clinical Case of Secondary Central Nervous System Involvement without Transformation in Hairy Cell Leukemia: A Case Report and Literature Review.

A Rare Clinical Case of Secondary Central Nervous System Involvement without Transformation in Hairy Cell Leukemia: A Case Report and Literature Review.

Journal: Acta haematologica
Published: April 13, 2023

An ectopic thymoma arising in the middle mediastinum that was difficult to distinguish from a lymph node metastasis.

An ectopic thymoma arising in the middle mediastinum that was difficult to distinguish from a lymph node metastasis.

Journal: Surgical case reports
Published: March 28, 2021

An Autopsy Case of Bing-Neel Syndrome: Discrepancy between the Radiological and Pathological Findings.

An Autopsy Case of Bing-Neel Syndrome: Discrepancy between the Radiological and Pathological Findings.

Journal: Internal medicine (Tokyo, Japan)
Published: March 29, 2019

What is the most appropriate regimen for untreated Waldenström macroglobulinemia? - An updated analysis of rituximab and half-dose CHOP therapy and cost effectiveness.

What is the most appropriate regimen for untreated Waldenström macroglobulinemia? - An updated analysis of rituximab and half-dose CHOP therapy and cost effectiveness.

Journal: Blood research
Published: January 31, 2019
Showing 1-12 of 13

Last Updated: 09/26/2026